Arman Murabia
Hospitalist · New Haven, CTNPI 1639557770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $26.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$253
- Boehringer Ingelheim$210
- GSK$143
- Jazz Pharmaceuticals Inc.$100
- Electromed, Inc.$88
- Regeneron Healthcare Solutions, Inc.$83
- plus $382 from 11 others
What the payments were for
- Food & beverage$1,15892%
- Education$1008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $253 |
| Boehringer Ingelheim | 7 | $210 |
| GSK | 6 | $143 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| Electromed, Inc. | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Harmony Biosciences LLC | 3 | $50 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $45 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| 3b Medical, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $31 |
| Amgen | 2 | $29 |
| Insmed, Inc. | 1 | $29 |
| Mylan Specialty L.p. | 1 | $29 |
| Baxter Healthcare | 1 | $27 |
How this compares
$1,258 in reported general payments places this provider in the 90th percentile of 349 hospitalist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,422 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $122 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in New Haven
- Shuta IshibeNew Haven$3K
- Cassandra MullenNew Haven$2K
- Rajat VirmaniNew Haven$1K
- Timothy KimNew Haven$1K
- Olutayo ImevboreNew Haven$1K
- Anthony IsedehNew Haven$1K
- Alan ZakkoNew Haven$1K
- Bashar KadhimNew Haven$754
- Suparna SahaNew Haven$748
- Andrew NunnoNew Haven$609
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.